PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Charnwood Molecular

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Compound Profiling - Charnwood Molecular Launches New Unique Profiling Service - Chemistry - Charnwood Molecular, a provider of chemistry services to the biotechnology, fine chemical and pharmaceutical industries, has partnered with Hybrigenics, to launch a new service which identifies interactions between small molecules and protein targets
Compound Profiling - Charnwood Molecular Launches New Unique Profiling Service - Chemistry

 

NewswireToday - /newswire/ - Whalley, Lancashire, United Kingdom, 2014/10/31 - Charnwood Molecular, a provider of chemistry services to the biotechnology, fine chemical and pharmaceutical industries, has partnered with Hybrigenics, to launch a new service which identifies interactions between small molecules and protein targets.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Charnwood Molecular’s involvement in the partnership sees the company using its expertise to link molecules for further analysis by Paris-based Hybrigenics, using their yeast molecular biology machinery. The venture is the result of a two year long commercial trialling phase, which was supported by European funding.

The project is the result of a joint development venture amounting to a total investment of nearly one million Euros, which has been supported up to 40% of the costs by a European Union subsidy under the Eurostars® programme.
Using a chemical linkage adaptation of its optimized “yeast two-hybrid” technology, renamed “yeast chemical-hybrid” (YChemH), Hybrigenics Services screens the molecule provided by Charnwood Molecular as a “bait” against its cDNA or genomic libraries expressing millions of “prey” protein fragments to identify target proteins with which this tested molecule interacts.

These exhaustive screenings can be of interest from both safety and efficiency angles. It is hoped that the technology may uncover a full range of related targets, accounting for the whole spectrum of therapeutic activities of a drug (so-called “on-targets”) and/or explain unexpected side effects exerted through unsuspected targets (so-called “off-targets”). Some drugs are active in whole cellular or animal models, but their active mechanisms remain unknown: the YChemH technology may find a relevant target for these “orphan” drugs, in a process called “drug de-orphanisation”. It may also be relevant for widely used chemicals in every day products to ascertain that they do not interact with any protein.

“This new service offering covers a whole new area of involvement for Charnwood in protein interaction screening: with small molecules, making it unique. The venture has been conceived and developed to answer the unmet needs of the pharmaceutical industry and highlights our expertise in chemistry. This, alongside the biological expertise held at Hybrigenics, means that we are involved in developments at the cutting edge of the biotech/chemical sector” said Sylvain Blanc, Business Development Manager of Charnwood Molecular.

The venture comes at a key time for Charnwood Molecular as the company expands, having recently acquired a new laboratory site within BioCity, Nottingham, UK.

• Founded in 1998 as Charnwood Catalysis Ltd., a "spin-out" from Loughborough University, by Prof. Steve Allin and Prof. Phil Page to exploit expertise in asymmetric synthesis and catalysis.

• Rebranded as Charnwood Molecular in 2002, the company builds on its enviable reputation for research and synthesis and expands to become a leading chemistry-based CRO serving the global chemical, pharmaceutical and biotechnology industries.

• In 2003 Charnwood Molecular relocates from Loughborough University into newly-refurbished premises containing three state-of-the-art research laboratories.

• In 2012, to serve the growing demand for its medicinal chemistry services, Charnwood Molecular expands into an additional research facility within BioCity, Nottingham.

• Charnwood Molecular's portfolio of services is wide and includes:

• Medicinal Chemistry (library design for drug discovery, modelling, synthesis and optimization)
• Custom Synthesis preparation of key chemical intermediates on up to 20-litre scale
• Contract Research, including route design, development and optimization
• Analytical Chemistry Support

• In 2013 Charnwood Molecular, in partnership with French company Hybrigenics Services, introduces a new service to its clients to identify interactions between bioactive small molecules and their protein targets based. This internal research and development was supported by European Union "Eurostars" funding.

• Charnwood Molecular can provide additional high-value expertise and input into clients’ projects through its carefully selected partnership agreements.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Charnwood Molecular

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Compound Profiling - Charnwood Molecular Launches New Unique Profiling Service - Chemistry

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Paul Hughes - Charnwood-Molecular.com 
+44(0)79 3190 3628 p.hughes[.]charnwood-molecular.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Charnwood Molecular securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Charnwood Molecular / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Sparta Systems Broadens Partnership with TrackWise Implementation Specialist Equality Systems
Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)